Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Budesonide

Urvashi K. Kalola  1 , Shashikanth Ambati  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Budesonide

Urvashi K. Kalola et al.
Free Books & Documents

Excerpt

Budesonide is a medication used to manage and treat inflammatory diseases, mainly affecting the airways and gastrointestinal tract. It is in the corticosteroid class of medications. This activity reviews the indications, mechanism of action, and contraindications, adverse event profiles, monitoring, and other key elements of budesonide therapy in the clinical setting as relates to the essential points needed by members of an interprofessional team managing the care of the patients with inflammatory diseases, and related conditions.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Urvashi Kalola declares no relevant financial relationships with ineligible companies.

Disclosure: Shashikanth Ambati declares no relevant financial relationships with ineligible companies.

References

    1. Mellon M. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group. J Allergy Clin Immunol. 1999 Oct;104(4 Pt 2):191-9. - PubMed
    1. Hashemian SM, Mortaz E, Jamaati H, Bagheri L, Mohajerani SA, Garssen J, Movassaghi M, Barnes PJ, Hill NS, Adcock IM. Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells. J Crit Care. 2018 Apr;44:161-167. - PubMed
    1. Rezaie A, Kuenzig ME, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH, Kaplan GG, Seow CH. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2015 Jun 03;2015(6):CD000296. - PMC - PubMed
    1. Naganuma M, Aoyama N, Tada T, Kobayashi K, Hirai F, Watanabe K, Watanabe M, Hibi T. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study. J Gastroenterol. 2018 Apr;53(4):494-506. - PMC - PubMed
    1. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 Jul 01;11(7):785-791. - PMC - PubMed

Publication types

LinkOut - more resources